Search results
Merck's (MRK) Chronic Cough Drug Gets Another CRL From FDA
Zacks via Yahoo News· 7 months agoPer the FDA, the data submitted by Merck (MRK) for its chronic cough drug did not provide sufficient...
Milestone Pharma (MIST) Down on Regulatory Update for Etripamil
Zacks via Yahoo News· 6 months agoMilestone Pharma (MIST) plunges 31% following an RTF letter from the FDA due to insufficient data to...
Biotech Stock Roundup: BBIO, ARGX Soar on Study Results, APLS Down on Safety Issues
Zacks via Yahoo News· 12 months agoIt was a busy week for the biotech sector, with many important regulatory and pipeline updates....
The Zacks Analyst Blog Highlights AVEO Pharmaceuticals, Cabaletta Bio, Verona Pharma and Wave Life...
Zacks via Yahoo News· 2 years agoFor Immediate Release Chicago, IL – January 3, 2023 – Zacks.com announces the list of stocks...
Lilly's (LLY) Donanemab Slows Alzheimer's Disease Progression
Zacks via Yahoo News· 12 months agoData from a phase III study shows that treatment with Eli Lilly's (LLY) donanemab slowed cognitive...
Biotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More
Zacks via Yahoo News· 3 months agoPipeline and regulatory updates continue to be in focus in the biotech sector. While nothing much...
Gritstone (GRTS) Plummets 58% in a Week: Here's Why
Zacks via Yahoo News· 3 months agoGritstone (GRTS) plunges after a mid-stage study evaluating its personalized cancer vaccine in certain patients with colorectal cancer failed to achieve...
Humanigen (HGEN) Plunges as COVID Study Fails to Meet Goal
Zacks via Yahoo News· 2 years agoThe NIAID's ACTIV-5/BET-B study evaluating Humanigen's (HGEN) lenzilumab plus remdesivir in...
Vir Biotechnology (VIR) Down on Influenza Study Failure
Zacks via Yahoo News· 12 months agoShares of Vir Biotechnology VIR plunged 44.90% after the company announced that the mid-stage...
Regulus (RGLS) Up on Top-Line Data from Kidney Disease Study
Zacks via Yahoo News· 2 years agoRegulus Therapeutics (RGLS) reports positive top-line data from a phase I single-dose ascending...